| 1 |
35322226 | RNA-targeting and gene editing therapies for transthyretin amyloidosis. | 2022 Mar 23 |
1 |
| 2 |
33155274 | Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis. | 2021 Mar |
1 |
| 3 |
30561247 | Inotersen (transthyretin-specific antisense oligonucleotide) for treatment of transthyretin amyloidosis. | 2019 Feb |
2 |
| 4 |
28906150 | Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy. | 2017 Dec |
1 |
| 5 |
27355239 | Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides. | 2016 Sep |
3 |
| 6 |
27584576 | Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells. | 2016 |
1 |
| 7 |
22494066 | Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. | 2012 Jun |
3 |
| 8 |
20462362 | Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment. | 2010 Jun |
7 |
| 9 |
16421881 | Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides. | 2006 May |
1 |